Search Results

No Results

    See all results

    Sorry, I don't understand. Please try again
    1. United States/
    2. Update on IMBRUVICA® (ibrutinib) U.S. Accelerated Approvals for Mantle Cell Lymphoma and Marginal Zone Lymphoma Indications

    Update on IMBRUVICA® (ibrutinib) U.S. Accelerated Approvals for Mantle Cell Lymphoma and Marginal Zone Lymphoma Indications

    April 6, 2023
    April 6, 2023

    Download the PDF